JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer
JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer
Not yet recruiting · NCT06892431 · Registry updated 2025-03-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer | Disease Attributes, Head and Neck Neoplasms, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pharyngeal Diseases, Recurrence, Stomatognathic Diseases, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Not yet recruiting | Phase 2 | 2025-03-25 | NCT06892431 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai JMT-Bio Inc. | 30 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||